Reuters logo
BRIEF-Diurnal announces grant of U.S. patent for steriod hormone drug
September 6, 2017 / 6:31 AM / 17 days ago

BRIEF-Diurnal announces grant of U.S. patent for steriod hormone drug

Sept 6 (Reuters) - DIURNAL GROUP PLC:

* ‍DIURNAL ANNOUNCES GRANT OF FIRST US PATENT FOR CHRONOCORT​

* ‍COMPOSITION OF MATTER PATENT PROVIDES PROTECTION UNTIL 2033 IN KEY US MARKET WHERE CHRONOCORT HAS ALREADY RECEIVED ORPHAN DRUG DESIGNATION​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below